Funding This work was supported by General Projects of National Natural Science Foundation of China in 2021 (82174187), 2022 Leading Talents of Science and Technology Innovation in Zhongyuan (234200510028), and Leading Talent Project of Traditional Chinese Medicine in Henan Province (No
Now a growing number of researchers, payers and providers are exploring deliberate "deprescription," which aims to taper some patients off their medication after they have taken it for a certain amount of time or lost a certain amount of weight
These medications work by helping regulate appetite, slowing stomach emptying, and improving feelings of fullness, making it easier for many patients to reduce calorie intake and lose weight
A Harvard study published in JAMA Ophthalmology found that diabetic patients taking Semaglutide, which is the active ingredient in Ozempic, Wegovy, and Rybelsus, developed NAION at nearly five times the rate of those taking other medications over a three-year period
Before choosing to enroll in a weight loss program with Hims & Hers, look around to find more affordable options with no gimmicks